Valeant, searching for cash, nears $2B sale of its Bausch & Lomb surgery business
admin 6th June 2017 Uncategorised 0Valeant Pharmaceuticals, on a mission to raise cash and pay down debt, is in talks to sell its Bausch & Lomb eye surgery business to Germany-based Carl Zeiss Meditec, Finanzen reported, citing Bloomberg.
More: Valeant, searching for cash, nears B sale of its Bausch & Lomb surgery business
Source: fierce